Aerovate Therapeutics Inc (AVTE) — Working Capital to Net Assets Ratio

Latest as of March 2025: 99.9%

Aerovate Therapeutics Inc (AVTE) has a Working Capital to Net Assets ratio of 99.9% as of March 2025. Working capital of $74.96 Million (current assets of $77.37 Million minus current liabilities of $2.42 Million) is measured against net assets of $75.05 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Aerovate Therapeutics Inc (AVTE) defensive interval to measure how many days the company can operate on defensive assets alone.

WC/NA Ratio

99.9%
Working Capital / Net Assets

Working Capital

$74.96 Million
USD

Current Assets

$77.37 Million
USD

Current Liabilities

$2.42 Million
USD

Aerovate Therapeutics Inc Working Capital to Net Assets (2019–2024)

This chart shows how Aerovate Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of March 2025, the ratio stands at 99.9%, reflecting working capital of $74.96 Million against net assets of $75.05 Million USD. For the complete balance sheet picture, see Aerovate Therapeutics Inc (AVTE) total assets.

Annual Working Capital to Net Assets for Aerovate Therapeutics Inc (2019–2024)

The table below presents the year-by-year Working Capital to Net Assets ratio for Aerovate Therapeutics Inc from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of Aerovate Therapeutics Inc to evaluate the company's liquid asset resilience ratio.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2024 99.8% $76.29 Million $76.43 Million $80.12 Million $3.83 Million ▲ +2.4 pp
2023 97.4% $106.59 Million $109.46 Million $124.23 Million $17.64 Million ▼ -0.2 pp
2022 97.6% $123.71 Million $126.74 Million $131.50 Million $7.78 Million ▼ -2.0 pp
2021 99.6% $171.78 Million $172.42 Million $174.33 Million $2.55 Million ▲ +121.4 pp
2020 -21.7% $2.90 Million $-13.34 Million $4.68 Million $1.77 Million ▲ +56.7 pp
2019 -78.4% $2.86 Million $-3.64 Million $3.51 Million $657.00K
pp = percentage points